A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Isolation of CD 90+ Fibroblast/Myofibroblasts from Human Frozen Gastrointestinal Specimens

9.4K views

⸱

DOI:

10.3791/53691

⸱

January 31st, 2016

 ,  ,  ,  ,  , 

Corresponding Authors: Iryna V. Pinchuk <ivpinchu@utmb.edu>

In This Article

Summary

Here, a protocol to isolate and establish primary fibroblast/myofibroblast (MF) cultures from frozen gastric, small intestinal, and colonic tissue-yielding cells with a MF phenotype-is presented. These cells express CD90, α-SMA and vimentin. MFs can be used for a variety of functional assays including enzymatic activity and cytokine production.

Abstract

Fibroblasts/myofibroblasts (MFs) have been gaining increasing attention for their role in pathogenesis and their contributions to both wound healing and promotion of the tumor microenvironment. While there are currently many techniques for the isolation of MFs from gastrointestinal (GI) tissues, this protocol introduces a novel element of isolation of these stromal cells from frozen tissue. Freezing GI tissue specimens not only allows the researcher to acquire samples from worldwide collaborators, biobanks, and commercial vendors, it also permits the delayed processing of fresh samples. The described protocol will consistently yield characteristic spindle-shaped cells with the MF phenotype that express the markers CD90, α-SMA and vimentin. As these cells are derived from patient samples, the use of primary cells also confers the benefit of closely mimicking MFs from disease states-namely cancer and inflammatory bowel diseases. This technique has been validated in gastric, small bowel, and colonic MF primary culture generation. Primary MF cultures can be used in a vast array of experiments over a number of passage and their purity assessed by both immunocytochemistry and flow cytometry analysis.

Introduction

Myofibroblasts/fibroblasts (MFs) represent an abundant population of cells in gastrointestinal (GI) mucosa. These stromal cells are located just beneath the epithelium and form an interconnected network within mucosal lamina propria in the gut. MFs are not only responsible for the deposition of the extracellular matrix, but through paracrine regulation may influence electrolyte transport, restitution, and barrier function of the adjacent epithelium1, 2. Furthermore, MFs have been shown to play a key role in inflammation and tissue remodeling3, 4. Myofibroblasts are a critical part of the tumor microenvironment, where they are also known as cancer....

Access restricted. Please log in or start a trial to view this content.

Protocol

The protocol for obtaining discarded human tissue from surgical patients and the establishment of primary cultures was approved by the University of Texas Medical Branch and University of New Mexico Institutional Review Boards. The general requirements for the procurement of human tissue specimens is described below. Note that since MFs may be isolated from frozen tissue, biobanks and commercial vendors are also viable options.

1. Obtain Human Tissue

  1. Submit a protocol to obtain human colon tissue to the institutional review board for approval.
  2. Establish collaborations with general surgeons and/or colorectal surgeons in....

Access restricted. Please log in or start a trial to view this content.

Results

Using this enzymatic digestion protocol, we have consistently been able to isolate and grow MF population gut CD90+ mucosal stromal cells from GI surgical specimens and biopsies (Figure 1). Visible MF colony proliferation could be observed on day 2 - 5 after seeding mononuclear cell suspensions into 6 well plates (Figure 1A-B). The MF primary cultures reach ~ 50 - 70 % confluence by day 7 - 11 (Figure 1C-D).

Access restricted. Please log in or start a trial to view this content.

Discussion

While this protocol was developed for the research application only, in the light of growing critical importance of stromal cells as a potential cancer prognostic biomarkers and therapeutic target, the ability to freeze "functional" biospecimens for later use offers a significant advantage. This represents a unique advantage for creation of clinical biorepository, which may serve as additional tools serving to advance the development of personalized medicine10, 11. Similar to findings previously report.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was supported by National Institute of Health (1R01DK103150-01A1, T32 DK007639, R01CA175803, K08CA125209) and the Institute for Translational Sciences at the University of Texas Medical Branch, and a Clinical and Translational Science Award (8UL1TR000071).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
MEM, 1xCorningMT-10-010-CV
Hanks' Balanced Salt SolutionSigma-AldrichH6648
Sodium pyruvateSigma-AldrichS8636
Antibiotic-Antimycotic, 100xGibco15240-062
Ciprofloxacin HClCorning61-277-RF
L-Glutamine, 100xCorning25-005-CI
MEM Nonessential Amino AcidsCorning25-025-CI
Dimethyl Sulfoxide (DMSO) Hybri-MaxSigma-AldrichD2650
DL-Dithiothreitol solution (DTT)Sigma-Aldrich646563
0.5 M EDTA, pH 8.0Cellgro46-034-CI
DNAseWorthingtonLS002139
Collagenase from Clostridium histolyticum, Type ISigma-AldrichC1639
Collagenase from Clostridium histolyticum, Type IISigma-AldrichC1764
Collagenase from Clostridium histolyticum, Type IVSigma-AldrichC5138
Accumax cell dissociation solutionSigma-AldrichA7089
gentleMACS C TubesMiltenyi Biotec130-093-237
gentleMACS DissociatorMiltenyi Biotec130-093-235
Countess Automated Cell CounterInvitrogenC10227
Cell Strainer (70 µm)Corning352350
PE Mouse Anti-Human VimentinBD Biosciences562337Clone RV202
FITC Monoclonal Anti-Actin, α-Smooth MuscleSigma-AldrichF3777Clone 1A4
APC Mouse Anti-Human CD90BD Biosciences559869Clone 5E10

References

  1. Yamaguchi, H., et al. Stromal Fibroblasts Mediate Extracellular Matrix Remodeling and Invasion of Scirrhous Gastric Carcinoma Cells. PLoS ONE. 9, e85485(2014).
  2. Mullan, N., Hughes, K. R., Mahida, Y. R.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Fibroblast IsolationMyofibroblast IsolationFrozen Tissue ProcessingCollagenase DigestionFlow Cytometry AnalysisCD90 Positive CellsGastrointestinal TissueStromal Cell CultureImmunocytochemistry AssessmentTissue Dissociation